Skip to content

Clinical trials

Hypertension, Pregnancy-Induced trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pregnancy-Induced Country / region: United States Clear all

106 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20094
20122
20142
20153
20164
20175
20187
20195
20207
202114
20227
202312
202413
202510
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Recruiting25
Terminated10
Active, not recruiting9
Unknown status6
Withdrawn6
Not yet recruiting3
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Pennsylvania6
Columbia University4
Massachusetts General Hospital4
Brigham and Women's Hospital3
Medical College of Wisconsin3
Northwestern University3
Ohio State University3
The University of Texas Health Science Center, Houston3
University of Alabama at Birmingham3
University of North Carolina, Chapel Hill3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pregnancy-Induced106
Pre-Eclampsia68
Hypertension34
Eclampsia13
Diabetes, Gestational10
Pregnancy Complications10
Cardiovascular Diseases9
Toxemia9
Obesity8
Overweight5

Trials

Showing 26 to 50 of 106. Each trial links to its page on Pharma Observatory.

6 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.